You have 9 free searches left this month | for more free features.

IL-27

Showing 1 - 25 of 6,277

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

A Biomarker Predicating Early Onset Neonatal Sepsis

Recruiting
  • Neonatal Sepsis, Early-Onset
  • IL27, PCT, CRP, Blood culture
  • Abu Dhabi, United Arab Emirates
    Mansoura University Children Hospital
Oct 18, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis

Not yet recruiting
  • Rheumatoid Arthritis
    • (no location specified)
    Oct 4, 2022

    Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric

    Active, not recruiting
    • Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
    • +3 more
    • Phoenix, Arizona
    • +219 more
    Aug 16, 2022

    Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients Trial in Assiut (Quantitative Real Time Polymerase chain

    Recruiting
    • Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients
    • Quantitative Real Time Polymerase chain reaction (qRT-PCR)
    • ELISA and colorimeter
    • Assiut, Egypt
      Biochemistry department,Faculty of medicine
    Oct 10, 2023

    Diabetes, Type 2 Trial in Wasit (Colostrum Capsule 500 mg (Colostrum® 500 mg Veg Capsules, nowfoods®, Illinois, USA), Placebo)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Colostrum Capsule 500 mg (Colostrum® 500 mg Veg Capsules, nowfoods®, Illinois, USA)
    • Placebo
    • Wasit, Iraq
      Al-Zahraa Teaching Hospital
    Aug 22, 2023

    Myeloma Trial in Houston (Fludarabine phosphate, Cyclophosphamide, NY-ESO-1 TCR/IL-15 NK)

    Not yet recruiting
    • Myeloma
    • Fludarabine phosphate
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 27, 2023

    Early Disease Onset Trial (Puva (psoralin and uva ))

    Not yet recruiting
    • Early Disease Onset
    • Puva (psoralin and uva )
    • (no location specified)
    Sep 27, 2023

    Autoantibodies, Interleukin-6 Trial in Frederiksberg (Oral Glucose Tolerance Test, Cycling test)

    Recruiting
    • Autoantibodies
    • Interleukin-6
    • Oral Glucose Tolerance Test
    • Cycling test
    • Frederiksberg, Denmark
      Frederiksberg Hospital
    May 10, 2023

    Diagnostic and Prognostic Biomarkers for IgG4-related Disease.

    Recruiting
    • Immunoglobulin G4-Related Disease
    • blood test
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Jun 12, 2023

    Diabetes, Periodontitis, Melatonin Trial in Rize (Melatonin 3 MG)

    Completed
    • Diabetes Mellitus
    • +3 more
    • Melatonin 3 MG
    • Rize, Turkey
      Yagmur Sarac Gul
    May 18, 2023

    DuringEuploid Frozen Embryo Transfer inNatural Cycle

    Not yet recruiting
    • Infertility, Female
    • Endometrin 100Mg Vaginal Insert
    • Estradiol Valerate
    • Abu Dhabi, United Arab Emirates
      ART Fertility Clinics LLC
    Jul 22, 2022

    Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

    Not yet recruiting
    • Pericarditis
    • IL1RA Antibody Assay
    • suPAR Testing
    • Homburg, Germany
    • +8 more
    Jun 22, 2023

    Pulmonary Immune Cell-microbiome Interactions in Healthy Lung

    Recruiting
    • Healthy
    • Bronhcoalvelar lavage
    • Hvidovre, Denmark
      Hvidovre Hospital, University of Copenhagen
    Apr 27, 2023

    Keloid, Stem Cell Trial in Jakarta Pusat (umbilical cord-derived mesenchymal stem cells (UC-MSC), umbilical cord-derived

    Completed
    • Keloid
    • Stem Cell
    • umbilical cord-derived mesenchymal stem cells (UC-MSC)
    • +2 more
    • Jakarta Pusat, DKI Jakarta, Indonesia
      RSPAD Gatot Soebroto
    Jul 1, 2023

    Physical Activity, Resistance Exercise, Inflammation Trial in Culiacán (Resistance exercise training plus hypocaloric diet,

    Recruiting
    • Physical Activity
    • +3 more
    • Resistance exercise training plus hypocaloric diet
    • Hypocaloric diet
    • Culiacán, Sinaloa, Mexico
      Autonomous University of Sinaloa
    Jul 28, 2022

    Scleroderma, Systemic Trial in Athens (MABp1 (Bermekimab) OR Placebo, MABp1 (Bermekimab))

    Completed
    • Scleroderma, Systemic
    • MABp1 (Bermekimab) OR Placebo
    • MABp1 (Bermekimab)
    • Athens, Attiki, Greece
    • +1 more
    Sep 28, 2022

    Patients Receiving Biotherapies Targeting IL-23/IL-17 Axis in

    Recruiting
    • Psoriasis
    • Blood sample
    • +2 more
    • Paris, Ile De France, France
      Lars ROGGE
    Oct 6, 2022

    Metastatic Renal Cell Carcinoma Trial in Boston (HD IL2)

    Completed
    • Metastatic Renal Cell Carcinoma
    • HD IL2
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jun 20, 2022

    Endodontically Treated Teeth Trial in Cairo (Intracanal Diode laser irradiation, Placebo)

    Completed
    • Endodontically Treated Teeth
    • Intracanal Diode laser irradiation
    • Placebo
    • Cairo, Egypt
      Faculty of Dentistry
    Nov 15, 2022

    IL6&8 in Malnourished Children With Acute Diarrhea

    Not yet recruiting
    • Acute Diarrhea
    • +2 more
    • Evaluation of serum levels of IL-6 and IL-8
    • Sohag, Egypt
      Sohag University Hospital
    Dec 21, 2021

    Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

    Recruiting
    • Colorectal Cancer
    • +11 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jan 18, 2023

    IL-6 and Its Receptor Antagonists in Children's Severe Sepsis.

    Withdrawn
    • Critical Illness Sepsis, Severe
      • (no location specified)
      Jun 13, 2022

      MDD Trial (Tocilizumab, Placebo, Whole-Body Hyperthermia)

      Not yet recruiting
      • Major Depressive Disorder
      • (no location specified)
      Aug 23, 2022